Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene protein K-Ras is a small GTPase that acts as a molecular switch in cellular signal transduction pathways, regulating cell proliferation, differentiation, and survival. Activating mutations in KRAS, particularly at codons 12 or 13, are common in human cancers, leading to constitutive activation of downstream signaling and tumorigenesis. Recent drug development efforts have focused on targeting specific mutant forms like KRAS^G12C^.
Inhibition of mutant K-Ras protein (e.g., KRAS^G12C^) to prevent activation of downstream signaling pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein K-Ras (K-Ras).